AMRX - Amneal Pharmaceuticals Inc. (AMRX) CEO Chintu Patel on Q1 2021 Results - Earnings Call Transcript
Amneal Pharmaceuticals, Inc. (AMRX) Q1 2021 Earnings Conference Call May 07, 2021, 08:30 ET Company Participants Anthony DiMeo - IR Chintu Patel - Co-Founder, Co-CEO & Director Chirag Patel - Co-Founder, Co-CEO, President & Director Anastasios Konidaris - EVP & CFO Joseph Todisco - EVP & Chief Commercial Officer, Specialty Conference Call Participants Gregory Gilbert - Truist Securities Daniel Busby - RBC Capital Markets David Amsellem - Piper Sandler & Co. Lucas Lee - Raymond James & Associates Dana Flanders - Guggenheim Securities Nathan Rich - Goldman Sachs Group Gary Nachman - BMO Capital Markets Presentation Operator Hello, and welcome to the Amneal First Quarter 2021 Conference Call. [Operator Instructions]. I would now like to turn the call over to Amneal's Head of Investor Relations, Tony DiMeo. Anthony DiMeo Good morning, and thank you for joining us for Amneal's First Quarter 2021 Earnings Call. Earlier this morning, we issued a
For further details see:
Amneal Pharmaceuticals, Inc. (AMRX) CEO Chintu Patel on Q1 2021 Results - Earnings Call Transcript